Rhythm’s withdrawl the latest evidence the biotech IPO boom is over (Video)

In further evidence that the biotech IPO boom is over, Rhythm Pharmaceuticals withdrew its plans for an $86 million public offering...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.